For LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Combination Treatment as Potential First-Line Treatment of Patients with Advanced Unresectable Hepatocellular Carcinoma Not…
In Combination with KEYTRUDA as Therapy for Previously Treated Patients with Advanced and/or Metastatic non-MSI-H/pMMR Endometrial Carcinoma Tokyo, August 05,…
Tokyo, August 04, 2018: Eisai Co., Ltd. announced today that it has entered into an agreement to grant exclusive development…
Most of us don’t get the smallpox vaccine anymore, which means we’d be vulnerable to a bioterrorism attack using the…
The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval Shanghai, May 11,…
New Delhi, May 05, 2018: Porvair Filtration Group, an international leader in filtration and separation, offers validation services for its…
First FDA approved device to determine moving sperm (a key to male fertility) Test your sperm from the comfort of…
Experts forecast the industry’s biggest developments at Pharmapack Europe Paris, April 21, 2018: Pharmapack Europe (#pharmapackeu) – organised by UBM – closed…
Mumbai, April 21, 2018: Pharma major Lupin on Wednesday said that it has received tentative approval for its Testosterone Gel, 1.62…
New Delhi, April 08, 2018: Nestlé India in collaboration with the FDA Assam and Magic Bus India Foundation, commemorated the forthcoming…